lovastatin has been researched along with Cardiovascular Stroke in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.38) | 18.7374 |
| 1990's | 25 (59.52) | 18.2507 |
| 2000's | 16 (38.10) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pokrovskiĭ, AV; Suntsov, DS | 1 |
| McCarty, MF | 1 |
| Ahn, C; Aronow, WS | 1 |
| Bouzamondo, A; Corvol, JC; Hulot, JS; Lechat, P; Sanchez, P; Sirol, M | 1 |
| Baurand, A; Bergmann, MW; Dietz, R; El Jamali, A; Freund, C; Rechner, C | 1 |
| Abrahamowicz, M; Austin, PC; Eisenberg, MJ; Humphries, K; Pilote, L; Rahme, E; Tu, JV; Zhou, Z | 1 |
| Hodis, HN; Mack, WJ; Mahrer, PR; Selzer, RH; Vigen, C | 1 |
| Girotra, S; Mittleman, MA; Mukamal, KJ | 1 |
| Foody, JM; Galusha, D; Havranek, EP; Krumholz, HM; Masoudi, FA; Radford, MJ; Rathore, SS | 1 |
| Csont, T; Fekete, V; Ferdinandy, P; Giricz, Z; Janáky, T; Kocsis, GF; Kovács-Simon, A; Molnár, E; Odendaal, L; Pipis, J; van Rooyen, J | 1 |
| Jay, RH | 1 |
| Kjekshus, J; Pedersen, TR | 1 |
| Durrington, PN | 1 |
| Reynolds, T; Wierzbicki, A | 1 |
| Armitage, J; Collins, R; Fatemian, M; Kearney, E; Keech, A; Lawson, A; Lyon, V; MacMahon, S; Mindell, J; Wallendszus, K | 1 |
| Day, AP; Stansbie, D | 1 |
| Gladstone, P; Higginson, L; Kimball, B; LeMay, M; Lespérance, J; Waters, D | 1 |
| Shepherd, J | 1 |
| MacDonald, TM; MacFadyen, RJ; Mollon, I; Pringle, SD | 1 |
| Huttunen, J | 1 |
| Boccuzzi, SJ; Cook, T; Gladstone, P; Higginson, L; Hudgin, R; Krip, G; Lespérance, J; Waters, D | 1 |
| Pederson, JP; Weintraub, WS | 1 |
| Aumont, MC; Seknadji, P | 1 |
| Faergeman, O; Kjekshus, J; Olsson, AG; Pedersen, TR; Pyŏrälä, K; Thorgeirsson, G | 1 |
| Bhatnagar, D | 1 |
| Verheugt, FW | 1 |
| Carek, PJ; MacFarlane, LL | 1 |
| Werkö, L | 1 |
| Dotani, MI; Elnicki, DM; Gibson, CM; Jain, AC | 1 |
| Whitney, E | 1 |
| Durlach, V | 1 |
| Sprecher, DL | 1 |
| Auer, J; Eber, B | 1 |
| Böhm, M; Hamm, CW; Heeschen, C; Laufs, U; Snapinn, S; White, HD | 1 |
| Clearfield, M; Cook, TJ; Downs, JR; Gotto, AM; Pradhan, AD; Ridker, PM; Shih, J; Weis, SE | 1 |
| Sylvain-Moore, H; Worden, JP | 1 |
| Cohn, PF | 1 |
| Goldsmith, MF | 1 |
8 review(s) available for lovastatin and Cardiovascular Stroke
| Article | Year |
|---|---|
[Statins in practice of the vascular surgeon and cardiologist].
Topics: Aged; Anticholesteremic Agents; Cardiovascular Diseases; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Lovastatin; Male; Meta-Analysis as Topic; Myocardial Infarction; Myocardial Ischemia; Randomized Controlled Trials as Topic; Risk Factors; Time Factors | 2009 |
Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials.
Topics: Anticholesteremic Agents; Atorvastatin; Cholestyramine Resin; Clofibrate; Colestipol; Gemfibrozil; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Myocardial Infarction; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Regression Analysis; Risk Assessment; Risk Factors; Simvastatin; Stroke; Treatment Failure; Treatment Outcome | 2003 |
Statin therapy in clinical practice: new developments.
Topics: Angina Pectoris; Anticholesteremic Agents; Cholesterol; Enzyme Inhibitors; Female; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Middle Aged; Myocardial Infarction; Simvastatin | 1995 |
[Secondary prevention after myocardial infarction; rôle of platelet antiaggregants and hypolipemic agents].
Topics: Anticholesteremic Agents; Aspirin; Coronary Disease; Cost-Benefit Analysis; Gemfibrozil; Humans; Hypolipidemic Agents; Lovastatin; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Factors; Simvastatin | 1996 |
[Further studies are required: in spite of positive effects of statins many patients still develop myocardial infarction].
Topics: Anticholesteremic Agents; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Humans; Lovastatin; Myocardial Infarction | 1998 |
[Statins: intervention studies, facts and perspectives].
Topics: Adult; Aged; Anticholesteremic Agents; Arteriosclerosis; Coronary Disease; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Middle Aged; Myocardial Infarction; Stroke | 2001 |
Raising high-density lipoprotein cholesterol with niacin and fibrates: a comparative review.
Topics: Cholesterol, HDL; Clinical Trials as Topic; Coronary Disease; Drug Combinations; Female; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lovastatin; Male; Myocardial Infarction; Niacin; Ultrasonography | 2000 |
A clinical focus on statins.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Atorvastatin; Cholesterol; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Cost-Benefit Analysis; Down-Regulation; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lovastatin; Multicenter Studies as Topic; Myocardial Infarction; Practice Guidelines as Topic; Pravastatin; Pyrroles; Quality of Life; Randomized Controlled Trials as Topic; Simvastatin | 2001 |
11 trial(s) available for lovastatin and Cardiovascular Stroke
| Article | Year |
|---|---|
Relation of progression of coronary artery atherosclerosis to risk of cardiovascular events (from the Monitored Atherosclerosis Regression Study).
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Disease; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Proportional Hazards Models | 2005 |
Alcohol consumption, atherosclerotic progression, and prognosis among patients with coronary artery bypass grafts.
Topics: Alcohol Drinking; Anticholesteremic Agents; Anticoagulants; Cholesterol, HDL; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Disease Progression; Female; Graft Occlusion, Vascular; Humans; Lovastatin; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Prognosis; Prospective Studies; Risk Factors; Sensitivity and Specificity; Smoking; Warfarin | 2006 |
Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S).
Topics: Adult; Age Factors; Aged; Anticholesteremic Agents; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Double-Blind Method; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Middle Aged; Myocardial Infarction; Risk Factors; Scandinavian and Nordic Countries; Sex Factors; Simvastatin; Survival Rate | 1995 |
Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)
Topics: Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Double-Blind Method; Female; Follow-Up Studies; Humans; Lipids; Lovastatin; Male; Middle Aged; Myocardial Infarction; Simvastatin; Treatment Outcome | 1994 |
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
Topics: Adult; Aged; Angina Pectoris; Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Lipids; Lovastatin; Male; Middle Aged; Myocardial Infarction; Risk Factors; Simvastatin; Survival Analysis | 1994 |
Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality study.
Topics: Adult; Aged; Anticholesteremic Agents; Cholesterol; Coronary Disease; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Lipids; Liver Function Tests; Lovastatin; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Simvastatin; Survival Analysis; Survival Rate; Treatment Outcome | 1994 |
Design and baseline results of the Scandinavian Simvastatin Survival Study of patients with stable angina and/or previous myocardial infarction.
Topics: Adult; Aged; Angina Pectoris; Anticholesteremic Agents; Double-Blind Method; Ethics, Medical; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Myocardial Infarction; Scandinavian and Nordic Countries; Simvastatin; Time Factors | 1993 |
Design features of a controlled clinical trial to assess the effect of an HMG CoA reductase inhibitor on the progression of coronary artery disease. Canadian Coronary Atherosclerosis Intervention Trial Investigators Montreal, Ottawa, and Toronto, Canada.
Topics: Adult; Aged; Cholesterol; Clinical Trials as Topic; Coronary Angiography; Coronary Artery Disease; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Middle Aged; Myocardial Infarction; Survival Rate | 1993 |
Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy. CCAIT Study Group.
Topics: Adult; Angina, Unstable; Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Lovastatin; Male; Middle Aged; Myocardial Infarction; Placebos; Smoking; Triglycerides | 1996 |
Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
Topics: Anticholesteremic Agents; Arteriosclerosis; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Diabetic Angiopathies; Double-Blind Method; Female; Humans; Lovastatin; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Placebos; Prognosis; Risk Factors; Scandinavian and Nordic Countries; Simvastatin; Survival Rate; Time Factors; Triglycerides | 1997 |
Plasma homocysteine concentration, statin therapy, and the risk of first acute coronary events.
Topics: Acute Disease; Aged; Anticholesteremic Agents; C-Reactive Protein; Cholesterol, LDL; Coronary Artery Disease; Coronary Disease; Double-Blind Method; Female; Follow-Up Studies; Homocysteine; Humans; Lovastatin; Male; Middle Aged; Myocardial Infarction; Risk Factors | 2002 |
23 other study(ies) available for lovastatin and Cardiovascular Stroke
| Article | Year |
|---|---|
Policosanol safely down-regulates HMG-CoA reductase - potential as a component of the Esselstyn regimen.
Topics: Animals; Cholesterol, LDL; Clinical Trials as Topic; Cohort Studies; Diet, Vegetarian; Dietary Fats; Dietary Supplements; Double-Blind Method; Drug Costs; Enzyme Activation; Fatty Alcohols; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Insulin Resistance; Lovastatin; Myocardial Infarction; Platelet Activation; Protein Prenylation; Protein Processing, Post-Translational; Rabbits; Rats; rho GTP-Binding Proteins; Safety | 2002 |
Frequency of new coronary events in older persons with peripheral arterial disease and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug.
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Cholesterol, HDL; Cholesterol, LDL; Female; Follow-Up Studies; Health Services for the Aged; Humans; Hypercholesterolemia; Incidence; Lovastatin; Male; Middle Aged; Myocardial Infarction; New York; Peripheral Vascular Diseases; Pravastatin; Prospective Studies; Simvastatin; Treatment Outcome; Triglycerides | 2002 |
Statins inhibit reoxygenation-induced cardiomyocyte apoptosis: role for glycogen synthase kinase 3beta and transcription factor beta-catenin.
Topics: Animals; Apoptosis; beta Catenin; Caspase 3; Caspases; Cell Hypoxia; Cell Line; Cytoskeletal Proteins; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Lovastatin; Male; Myocardial Infarction; Myocytes, Cardiac; Pravastatin; Rats; Rats, Wistar; Trans-Activators; Ventricular Remodeling | 2004 |
Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect.
Topics: Aged; Atorvastatin; Cohort Studies; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lovastatin; Male; Mortality; Myocardial Infarction; Patient Compliance; Pravastatin; Proportional Hazards Models; Pyrroles; Retrospective Studies; Secondary Prevention; Simvastatin; Survival Analysis | 2005 |
Hydroxymethylglutaryl-CoA reductase inhibitors in older persons with acute myocardial infarction: evidence for an age-statin interaction.
Topics: Age Factors; Aged, 80 and over; Atorvastatin; Cholesterol, LDL; Drug Prescriptions; Fatty Acids, Monounsaturated; Female; Fluvastatin; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lovastatin; Male; Myocardial Infarction; Odds Ratio; Pravastatin; Pyridines; Pyrroles; Retrospective Studies; Survival Rate; Treatment Outcome | 2006 |
Lovastatin interferes with the infarct size-limiting effect of ischemic preconditioning and postconditioning in rat hearts.
Topics: Animals; Blotting, Western; Disease Models, Animal; Down-Regulation; Drug Administration Schedule; Enzyme Activation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Preconditioning, Myocardial; Lovastatin; Male; Mitogen-Activated Protein Kinase 1; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Ubiquinone | 2008 |
Lowering patients' cholesterol. Excluding patients from trials increases uncertainty.
Topics: Anticholesteremic Agents; Cholesterol; Humans; Lovastatin; Myocardial Infarction; Research Design; Simvastatin | 1995 |
Implications of 4S evidence on baseline lipid levels.
Topics: Cholesterol; Cholesterol, LDL; Coronary Disease; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lovastatin; Myocardial Infarction; Randomized Controlled Trials as Topic; Simvastatin; Triglycerides | 1995 |
Treatment of myocardial infarction and angina. Advice on reducing cholesterol should be included.
Topics: Angina Pectoris; Anticholesteremic Agents; Cholesterol; Humans; Lovastatin; Myocardial Infarction; Simvastatin | 1995 |
Biochemical diagnosis of myocardial infarction? Cardiac enzymes or caveat emptor.
Topics: Creatine Kinase; Diagnosis, Differential; Humans; Lovastatin; Male; Middle Aged; Muscular Diseases; Myocardial Infarction; Simvastatin | 1994 |
Implementation of the 4S study in first myocardial infarction.
Topics: Anticholesteremic Agents; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Myocardial Infarction; Simvastatin | 1996 |
[The cholesterol hypothesis has been proved true at last].
Topics: Adult; Aged; Angina Pectoris; Anticholesteremic Agents; Cholesterol; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Myocardial Infarction; Simvastatin | 1995 |
Atherosclerosis and restenosis: reflections on the Lovastatin Restenosis Trial and Scandinavian Simvastatin Survival Study.
Topics: Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Coronary Artery Disease; Death, Sudden, Cardiac; Humans; Lovastatin; Myocardial Infarction; Pravastatin; Randomized Controlled Trials as Topic; Recurrence; Scandinavian and Nordic Countries; Simvastatin; Survival Analysis | 1996 |
Therapy and clinical trials.
Topics: Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Female; Humans; Lipids; Lovastatin; Male; Myocardial Infarction; Pravastatin; Simvastatin | 1997 |
Aspirin, the poor man's statin?
Topics: Anticoagulants; Aspirin; Female; Humans; Lovastatin; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Pravastatin; Risk Factors; Warfarin | 1998 |
Lovastatin to prevent acute coronary events with average cholesterol levels.
Topics: Acute Disease; Aged; Angina, Unstable; Anticholesteremic Agents; Cholesterol; Coronary Disease; Death, Sudden, Cardiac; Double-Blind Method; Female; Humans; Lovastatin; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Reproducibility of Results; Treatment Outcome | 1998 |
Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting.
Topics: Aged; Anticholesteremic Agents; Arrhythmias, Cardiac; Atorvastatin; Cause of Death; Coronary Artery Bypass; Coronary Disease; Female; Heart Failure; Heptanoic Acids; Humans; Hypercholesterolemia; Incidence; Lovastatin; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Preoperative Care; Pyrroles; Recurrence; Retrospective Studies; Risk Factors; Simvastatin; Stroke; Treatment Outcome | 2000 |
The Air Force/Texas Coronary Atherosclerosis Prevention Study: implications for preventive cardiology in the general adult US population.
Topics: Aged; Angina, Unstable; Cholesterol, LDL; Coronary Artery Disease; Death, Sudden, Cardiac; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lovastatin; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic | 1999 |
Cholesterol-lowering drugs. Some drugs with demonstrated efficacy but different benefits in primary and secondary prevention.
Topics: Anticholesteremic Agents; Bezafibrate; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Female; Gemfibrozil; Humans; Hypercholesterolemia; Lovastatin; Male; Myocardial Infarction; Pravastatin; Treatment Outcome | 1999 |
Withdrawal of statins increases event rates in patients with acute coronary syndromes.
Topics: Acute Disease; Cholesterol; Clinical Trials as Topic; Comorbidity; Coronary Artery Disease; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heparin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Lovastatin; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Platelet Aggregation Inhibitors; Pravastatin; Proportional Hazards Models; Risk Factors; Simvastatin; Substance Withdrawal Syndrome; Survival Rate; Treatment Outcome; Troponin; United States | 2002 |
Lovastatin-associated rhabdomyolysis.
Topics: Aged; Diagnosis, Differential; Female; Humans; Lovastatin; Myocardial Infarction; Rhabdomyolysis | 1991 |
Silent myocardial ischemia--classification and management.
Topics: Angina Pectoris; Atenolol; Drug Therapy, Combination; Heart Function Tests; Hemodynamics; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Myocardial Infarction; Nifedipine; Risk Factors | 1990 |
New drugs address risk of heart attack, chances of surviving one.
Topics: Cholesterol; Humans; Lovastatin; Myocardial Infarction; Tissue Plasminogen Activator | 1987 |